Dr. Norah Lynn Henry is the Breast Oncology Disease Lead at the Rogel Cancer Center at the University of Michigan. She earned her degree in medicine at Washington University in St. Louis, Missouri, and her PhD in structural biology at Stanford University. She completed her internal medicine residency at Brigham and Women's Hospital in Boston before coming to the University of Michigan for her Hematology/Oncology fellowship. Since completing fellowship she has been on the faculty at the University of Michigan, except for the years 2016-2019 when she was at the University of Utah Huntsman Cancer Institute.
Dr. Henry specializes in the care of patients with all stages and all types of breast cancer, including metastatic breast cancer, inflammatory breast cancer, lobular breast cancer, and breast cancer in men. Her research focuses on personalizing treatment for breast cancer. She studies treatments for breast cancer as well as ways to manage symptoms and side effects that arise from the cancer or its treatment. Her goal is to provide effective treatments for breast cancer while maintaining the quality of life of each patients. In addition, she works with scientists at the University of Michigan to translate their lab findings into clinical trials.